Clinical Trial Update: Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of venetoclax plus azacitidine for acute myeloid leukemia in the post-transplant setting. The trial (NCT041…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Mixed Phenotype Acute Leukemia
• T-cell Acute Lymphoblastic Leukemia
• Therapy-related Acute Myeloid Leukemia

Drugs mentioned

• VIDAZA (AZACITIDINE)
• Venclyxto (Venetoclax)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Bilineal Leukemia, Acute Biphenotypic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING